P-58 Phase II study of irinotecan/cisplatin (IP) induction chemotherapy followed by concurrent twice-daily thoracic radiotherapy (RT) with etoposide/cisplatin (EP) for limited disease small cell lung cancer (LD-SCLC)

Lung Cancer ◽  
2003 ◽  
Vol 41 ◽  
pp. S105
Author(s):  
Ji-Youn Han ◽  
Kwan Ho Cho ◽  
Dae Ho Lee ◽  
Seong Min Yoon ◽  
Hyae Young Kim ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document